Skip to content

Reach Out: Emergency Department-Initiated Hypertension Behavioral Intervention Connecting Multiple Health Systems

Reach Out: Randomized Clinical Trial of Emergency Department-Initiated Hypertension Behavioral Intervention Connecting Multiple Health Systems

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03422718
Acronym
ReachOut ED
Enrollment
488
Registered
2018-02-06
Start date
2019-03-25
Completion date
2021-04-08
Last updated
2024-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

stroke, hypertension

Brief summary

This study evaluates a health theory based mobile health behavioral intervention to reduce blood pressure (BP) among hypertensive patients evaluated in a community Emergency Department (ED) setting.

Detailed description

Hypertension is the most important modifiable risk factor for cardiovascular disease, the leading cause of mortality in the United States. African Americans have the highest prevalence of hypertension of any race/ethnic group in the United States which largely contributes to their increased burden of stroke compared to non-Hispanic whites. In addition, uncontrolled hypertension is more common among socioeconomically disadvantaged populations than their counterparts. To improve health equity, new approaches to hypertension treatment focusing on health care systems and difficult-to-reach populations are needed. The Emergency Department (ED) represents a missed opportunity to identify and treat hypertension in difficult-to-reach populations. Currently, there are 136 million ED visits per year and nearly all have at least one blood pressure measured and recorded. African Americans and socioeconomically disadvantaged patients are disproportionally represented in the ED patient population and both are increasing. In the age of electronic health records and mobile health, the ED can feasibly become an integral partner in chronic disease management by programming the electronic health record to identify hypertensive patients and dispense a mobile health behavioral intervention. Facilitating ED follow up at primary care clinics is a key feature of the proposed intervention. Thereby leveraging the strengths of the ED and its large patient volume of uncontrolled, difficult-to-reach, hypertensive patients, with the strengths of the primary care clinics, continuity of care is the key to improving community wide utilization of health services and receipt of guideline concordant medical care. This study looks to determine which behavioral intervention components best contribute to a reduction in systolic blood pressure at one year through a multi-component theory based mobile health behavioral intervention. Sample Size and Population We originally planned to enroll approximately 960 patients into the eligibility phase. From this group, we estimate that 480 participants will report qualifying BPs and will be randomized to one of the eight intervention arms. We anticipate 240 participants will fully complete the 12 month, in person follow up visits. However, after accruing approximately 400 randomized participants, we noted lower than expected retention at 6 month visits. Therefore, we adjusted the maximum total number of enrollments and randomizations upwards by 50% each. The overall intention is to achieve approximately 240 protocol completers (attendees at 12-month visit). We will continue to monitor accrual and retention in order to achieve this target. Data Analysis The primary analysis will fit a linear regression model with the outcome of SBP change (baseline minus 12 months) and main effect-coded binary predictors of healthy behavior texts (yes vs. no), prompted BP self-monitoring frequency (high vs. low), and primary care provider visit scheduling and transportation (active vs. passive). Initial analyses will focus on the main effects. Additional analyses will include all the two-way interactions of the three intervention components (only considering interactions where at least one of the factors in the interaction demonstrates a sufficiently large main effect). The main secondary analyses will use time-to event (Cox Proportional Hazards) and logistic regression. For the endpoint of interest, (either time to first primary care visit, or the binary variable indicating attendance at two or more primary care visits within 1 year of randomization), the investigators will fit an adjusted regression model. Extension Study: Reach Out Cognition which will extend Reach Out data collection past the current 12 months to 15 and 18 months. During Reach Out Cognition, we aim to assess novel approaches to mobile health (mHealth) self-administered cognition and blood pressure (BP) measurements. These approaches may include cognitive assessments via mobile applications (apps) and Web-based surveys, and wireless BP measurements via Bluetooth-enabled blood pressure cuffs and apps. The study population for Reach Out Cognition will be drawn from Reach Out participants who complete the Reach Out intervention and are defined as: participants who complete the 12-month outcome assessment. We anticipate about 240 participants will have completed Reach Out's 12-month outcome assessment and will be eligible for Reach Out Cognition. Descriptive statistics will be used to evaluate acceptability, feasibility and satisfaction. The de-nominator is the number of Reach Out participants who complete the 12 month assessments. Regarding feasibility, we will separately determine the feasibility by mHealth measure (i.e. cognition vs. BP), phone type (i.e. smartphone vs. feature phone) and operating system type (iOS vs. Android vs. Windows) as a continuous and dichotomous (\>50% completion of each assessment type) measure. The satisfaction scale will be assessed for all participants. Given the difference in procedures by phone type, we will compare satisfaction between the smartphone and feature phone users using a Kruskal-Wallis test.

Interventions

BEHAVIORALHealthy Behavior Texts

Participants receive motivational health behavior texts

BEHAVIORALNo healthy behavior texts

Participants do not receive healthy behavior texts

BEHAVIORALBP Monitoring Daily Via Text Messaging

Daily text messages will prompt participants for BP by home cuff

BEHAVIORALBP Monitoring Weekly Via Text Messaging

Weekly text messages will prompt participants for BP by home cuff

Participants receive assistance scheduling physician appointment and transportation to those appointments

BEHAVIORALNo physician appointment and transportation scheduling

Participants do not receive assistance scheduling physician appointment or transportation

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age of 18 or greater * At least one BP with Systolic Blood Pressure (SBP) ≥ 160 or a Diastolic Blood Pressure (DBP) ≥ 100 (criteria 1) * If the patient has repeated measurements after achieving Criteria 1, at least one of the repeat BP remains SBP ≥ 140 or a DBP ≥ 90 * Must have cell phones with text-messaging capability and willingness to receive texts * Likely to be discharged from the ED

Exclusion criteria

* Unable to read English (\<1% at study site) * Prisoners * Pregnant * Pre-existing condition making one year follow-up unlikely * Terminal illness with death expected within 90 days * Current use of 3 or more antihypertensive agents * Patients with other serious medical conditions that prevent self-monitoring of BP * Critical illness with placement in resuscitation bay * Dementia/cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Change in Mean Systolic Blood Pressure12 monthsChange in 12-month Systolic Blood Pressure (SBP)

Secondary

MeasureTime frameDescription
Hazard Ratio Analysis of Participant Time From Enrollment Emergency Department Visit to the First PCP VisitBaseline ED visit (in days)Utilizing multivariable Cox regression analysis, the relationship between mHealth components and attendance at initial Primary Care Physician (PCP) appointment after Emergency Department visit is explored. The analysis adjusts for age, sex, race, presence of a primary care provider, and usage of blood pressure medications. The Hazard Ratio in this context is a measure indicating the relative risk of experiencing the event of interest (time to first PCP visit). A Hazard Ratio greater than 1 implies a greater risk of receipt of a first PCP appointment, and a Hazard Ratio less than 1 implies a lower risk of receipt of a first PCP appointment within 12-month follow-up. The use of Hazard Ratio in this context allows for the assessment of the impact of mHealth components on the timing of primary care engagement while accounting for potential confounding variables. This allows more valuable insights into the effectiveness of these components in facilitating access to primary care visits.
Odds Ratio Analysis of Participants Completing 2 or More Primary Care Visits12 monthsUtilizing logistic regression analysis, the probability of participants attending 2 or more primary care visits within a 12-month period is explored. The analysis adjusts for age, sex, race, presence of a primary care provider, and usage of blood pressure medications. The Odds Ratio in this context indicates the likelihood of an event occurring. A higher Odds Ratio suggests an increased likelihood of attending multiple primary care visits, while a lower Odds Ratio indicates a decreased likelihood. The use of Odds Ratio in this context is justified as it allows for the comparison of the likelihood of attending two or more primary care while accounting for covariates. This is useful in logistic regression analysis, where the outcome variable is binary (i.e., attending two or more primary care visits or not) and the focus is on understanding the association between predictor variables and the probability of the outcome.

Countries

United States

Participant flow

Recruitment details

This trial was conducted in Flint, Michigan, an urban, low-income, predominately Black community. Participants were recruited from the city's only safety-net ED (i.e., hospitals where over 25% of patients are Medicaid recipients). Enrollment occurred between March 2019 and March 2020.

Pre-assignment details

Participants entered a run-in phase of 3 weeks to determine whether a participant had persistently elevated BP. During this time, participants were prompted to text their BP once per week to the study team. Participants responding at least once and with at least one systolic BP ≥ 140 or a diastolic BP ≥ 90 were randomized.

Participants by arm

ArmCount
Arm 1
No healthy behavior texts BP Monitoring Weekly Via Text Messaging No physician appointment and transportation scheduling No healthy behavior texts: Participants do not receive healthy behavior texts BP Monitoring Weekly Via Text Messaging: Weekly text messages will prompt participants for BP by home cuff No physician appointment and transportation scheduling: Participants do not receive assistance scheduling physician appointment or transportation
62
Arm 2
Healthy Behavior Texts BP Monitoring Weekly Via Text Messaging No physician appointment and transportation scheduling Healthy Behavior Texts: Participants receive motivational health behavior texts BP Monitoring Weekly Via Text Messaging: Weekly text messages will prompt participants for BP by home cuff No physician appointment and transportation scheduling: Participants do not receive assistance scheduling physician appointment or transportation
60
Arm 3
No healthy behavior texts BP Monitoring Daily Via Text Messaging No physician appointment and transportation scheduling No healthy behavior texts: Participants do not receive healthy behavior texts BP Monitoring Daily Via Text Messaging: Daily text messages will prompt participants for BP by home cuff No physician appointment and transportation scheduling: Participants do not receive assistance scheduling physician appointment or transportation
63
Arm 4
Healthy Behavior Texts BP Monitoring Daily Via Text Messaging No physician appointment and transportation scheduling Healthy Behavior Texts: Participants receive motivational health behavior texts BP Monitoring Daily Via Text Messaging: Daily text messages will prompt participants for BP by home cuff No physician appointment and transportation scheduling: Participants do not receive assistance scheduling physician appointment or transportation
61
Arm 5
No healthy behavior texts BP Monitoring Weekly Via Text Messaging Physician appointment and transportation scheduling No healthy behavior texts: Participants do not receive healthy behavior texts BP Monitoring Weekly Via Text Messaging: Weekly text messages will prompt participants for BP by home cuff Physician appointment and transportation scheduling: Participants receive assistance scheduling physician appointment and transportation to those appointments
58
Arm 6
Healthy Behavior Texts BP Monitoring Weekly Via Text Messaging Physician appointment and transportation scheduling Healthy Behavior Texts: Participants receive motivational health behavior texts BP Monitoring Weekly Via Text Messaging: Weekly text messages will prompt participants for BP by home cuff Physician appointment and transportation scheduling: Participants receive assistance scheduling physician appointment and transportation to those appointments
61
Arm 7
No healthy behavior texts BP Monitoring Daily Via Text Messaging Physician appointment and transportation scheduling No healthy behavior texts: Participants do not receive healthy behavior texts BP Monitoring Daily Via Text Messaging: Daily text messages will prompt participants for BP by home cuff Physician appointment and transportation scheduling: Participants receive assistance scheduling physician appointment and transportation to those appointments
64
Arm 8
Healthy Behavior Texts BP Monitoring Daily Via Text Messaging Physician appointment and transportation scheduling Healthy Behavior Texts: Participants receive motivational health behavior texts BP Monitoring Daily Via Text Messaging: Daily text messages will prompt participants for BP by home cuff Physician appointment and transportation scheduling: Participants receive assistance scheduling physician appointment and transportation to those appointments
59
Total488

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005FG006FG007
12 Month Interventional Trial PeriodLost to Follow-up2616232721223625
12 Month Interventional Trial PeriodWithdrawal by Subject1113151278411
Optional Six Month Follow-Up PeriodChose Not to start 6 month extension811161417141410
Optional Six Month Follow-Up Periodineligible85221524
Optional Six Month Follow-Up PeriodLost to Follow-up811649836
Optional Six Month Follow-Up PeriodWithdrawal by Subject03001200

Baseline characteristics

CharacteristicTotalArm 8Arm 7Arm 6Arm 2Arm 5Arm 4Arm 1Arm 3
Age, Continuous45.5 years
STANDARD_DEVIATION 12.4
45.3 years
STANDARD_DEVIATION 12.2
45.6 years
STANDARD_DEVIATION 12.6
46.5 years
STANDARD_DEVIATION 12.2
47.7 years
STANDARD_DEVIATION 11.8
45.5 years
STANDARD_DEVIATION 12.5
45.3 years
STANDARD_DEVIATION 11.7
45.6 years
STANDARD_DEVIATION 12.6
49 years
STANDARD_DEVIATION 11.4
Currently have a primary care provider380 Participants43 Participants49 Participants47 Participants50 Participants47 Participants48 Participants51 Participants45 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
17 Participants1 Participants2 Participants2 Participants1 Participants3 Participants2 Participants3 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
471 Participants58 Participants62 Participants59 Participants59 Participants55 Participants59 Participants59 Participants60 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Prior medication for hypertension within the last 6 months273 Participants33 Participants36 Participants33 Participants35 Participants33 Participants34 Participants35 Participants34 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants0 Participants0 Participants0 Participants2 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
262 Participants30 Participants35 Participants39 Participants29 Participants35 Participants31 Participants29 Participants34 Participants
Race (NIH/OMB)
More than one race
22 Participants4 Participants2 Participants3 Participants2 Participants4 Participants1 Participants5 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
201 Participants25 Participants27 Participants19 Participants27 Participants19 Participants29 Participants28 Participants27 Participants
Region of Enrollment
United States
488 participants59 participants64 participants61 participants60 participants58 participants61 participants62 participants63 participants
Sex: Female, Male
Female
299 Participants37 Participants39 Participants38 Participants37 Participants36 Participants37 Participants37 Participants38 Participants
Sex: Female, Male
Male
189 Participants22 Participants25 Participants23 Participants23 Participants22 Participants24 Participants25 Participants25 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
deaths
Total, all-cause mortality
0 / 620 / 600 / 632 / 610 / 580 / 611 / 640 / 59
other
Total, other adverse events
0 / 620 / 600 / 630 / 610 / 580 / 610 / 640 / 59
serious
Total, serious adverse events
0 / 620 / 600 / 630 / 610 / 580 / 610 / 640 / 59

Outcome results

Primary

Change in Mean Systolic Blood Pressure

Change in 12-month Systolic Blood Pressure (SBP)

Time frame: 12 months

Population: numbers analyzed in each row show all the participants at the two timepoints (baseline and 12 month) for which data exists.

ArmMeasureGroupValue (MEAN)
Arm 1Change in Mean Systolic Blood PressureMean Change from Baseline-8.8 mmHg
Arm 1Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months135.1 mmHg
Arm 1Change in Mean Systolic Blood PressureMean @ Baseline142.8 mmHg
Arm 2Change in Mean Systolic Blood PressureMean Change from Baseline-8 mmHg
Arm 2Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months136.8 mmHg
Arm 2Change in Mean Systolic Blood PressureMean @ Baseline146.8 mmHg
Arm 3Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months138.2 mmHg
Arm 3Change in Mean Systolic Blood PressureMean @ Baseline143.9 mmHg
Arm 3Change in Mean Systolic Blood PressureMean Change from Baseline-3.2 mmHg
Arm 4Change in Mean Systolic Blood PressureMean Change from Baseline-8.8 mmHg
Arm 4Change in Mean Systolic Blood PressureMean @ Baseline144.7 mmHg
Arm 4Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months135.4 mmHg
Arm 5Change in Mean Systolic Blood PressureMean @ Baseline148 mmHg
Arm 5Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months136.9 mmHg
Arm 5Change in Mean Systolic Blood PressureMean Change from Baseline-7.3 mmHg
Arm 6Change in Mean Systolic Blood PressureMean @ Baseline145.8 mmHg
Arm 6Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months138.8 mmHg
Arm 6Change in Mean Systolic Blood PressureMean Change from Baseline-5.4 mmHg
Arm 7Change in Mean Systolic Blood PressureMean @ Baseline147.4 mmHg
Arm 7Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months139 mmHg
Arm 7Change in Mean Systolic Blood PressureMean Change from Baseline-6 mmHg
Arm 8Change in Mean Systolic Blood PressureMean Change from Baseline-4.9 mmHg
Arm 8Change in Mean Systolic Blood PressureMean @ Baseline149 mmHg
Arm 8Change in Mean Systolic Blood PressureMean of Median SBP @ 12 months138.5 mmHg
Secondary

Hazard Ratio Analysis of Participant Time From Enrollment Emergency Department Visit to the First PCP Visit

Utilizing multivariable Cox regression analysis, the relationship between mHealth components and attendance at initial Primary Care Physician (PCP) appointment after Emergency Department visit is explored. The analysis adjusts for age, sex, race, presence of a primary care provider, and usage of blood pressure medications. The Hazard Ratio in this context is a measure indicating the relative risk of experiencing the event of interest (time to first PCP visit). A Hazard Ratio greater than 1 implies a greater risk of receipt of a first PCP appointment, and a Hazard Ratio less than 1 implies a lower risk of receipt of a first PCP appointment within 12-month follow-up. The use of Hazard Ratio in this context allows for the assessment of the impact of mHealth components on the timing of primary care engagement while accounting for potential confounding variables. This allows more valuable insights into the effectiveness of these components in facilitating access to primary care visits.

Time frame: Baseline ED visit (in days)

Population: 211 is all of the participants in each of the eight arms who completed

ArmMeasureValue (NUMBER)
Arm 1Hazard Ratio Analysis of Participant Time From Enrollment Emergency Department Visit to the First PCP Visit0.9 hazard ratio
Arm 2Hazard Ratio Analysis of Participant Time From Enrollment Emergency Department Visit to the First PCP Visit1.2 hazard ratio
Arm 3Hazard Ratio Analysis of Participant Time From Enrollment Emergency Department Visit to the First PCP Visit1.2 hazard ratio
Secondary

Odds Ratio Analysis of Participants Completing 2 or More Primary Care Visits

Utilizing logistic regression analysis, the probability of participants attending 2 or more primary care visits within a 12-month period is explored. The analysis adjusts for age, sex, race, presence of a primary care provider, and usage of blood pressure medications. The Odds Ratio in this context indicates the likelihood of an event occurring. A higher Odds Ratio suggests an increased likelihood of attending multiple primary care visits, while a lower Odds Ratio indicates a decreased likelihood. The use of Odds Ratio in this context is justified as it allows for the comparison of the likelihood of attending two or more primary care while accounting for covariates. This is useful in logistic regression analysis, where the outcome variable is binary (i.e., attending two or more primary care visits or not) and the focus is on understanding the association between predictor variables and the probability of the outcome.

Time frame: 12 months

ArmMeasureValue (NUMBER)
Arm 1Odds Ratio Analysis of Participants Completing 2 or More Primary Care Visits0.7 Odds Ratio
Arm 2Odds Ratio Analysis of Participants Completing 2 or More Primary Care Visits1.8 Odds Ratio
Arm 3Odds Ratio Analysis of Participants Completing 2 or More Primary Care Visits1.7 Odds Ratio

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026